Related Experiment Video
Updated: Jun 22, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Triple negative breast cancer: clinicopathological characteristics and treatment strategies
Futoshi Akiyama1, Hirotaka Iwase
1Department of Pathology, Cancer Institute, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan. fakiyama@jfcr.or.jp
Abstract:
Triple negative breast cancer (TNBC) is defined as a subtype that is negative for estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2. We introduce the theme of the special issue concerning clinicopathological characteristics and prospective treatment strategies of TNBC. This special issue consists of five conference papers that have been agreed on by the speakers and the commentator of the symposium of the 16th Annual Meeting of the Japanese Breast Cancer Society in September 2008 in Osaka.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
